{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:43:03Z","timestamp":1789764183651,"version":"4.0.1"},"reference-count":171,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.expneurol.2025.115287","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T17:50:52Z","timestamp":1746381052000},"page":"115287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Gene-modified animal models of Parkinson's disease"],"prefix":"10.1016","volume":"390","author":[{"given":"Yong","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai-yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sugimoto","family":"Kazuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-qiao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-xin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2025.115287_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fnins.2018.00081","article-title":"Silencing of Glucocerebrosidase gene in Drosophila enhances the aggregation of Parkinson\u2019s disease associated alpha-Synuclein mutant A53T and affects locomotor activity","volume":"12","author":"Abul Khair","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.786076","article-title":"Mitochondria dysfunction in frontotemporal dementia\/amyotrophic lateral sclerosis: lessons from Drosophila models","volume":"15","author":"Anoar","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/path.4815","article-title":"PINK1 in the limelight: multiple functions of an eclectic protein in human health and disease","volume":"241","author":"Arena","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.expneurol.2025.115287_bb0020","first-page":"8","article-title":"Autophagy in synucleinopathy: the overwhelmed and defective machinery","author":"Arotcarena","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.expneurol.2025.115287_bb0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fnagi.2020.00097","article-title":"Glucocerebrosidase defects as a major risk factor for Parkinson\u2019s disease","volume":"12","author":"Avenali","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0030","article-title":"Depletion of ATP13A2 in adult brain induces a parkinsonian phenotype in mice and non-human primates","volume":"10","author":"Baekelandt","year":"2024","journal-title":"Npj Parkinson\u2019s Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0035","article-title":"The crucial role of VPS35 and SHH in Parkinson\u2019s disease: understanding the mechanisms behind the neurodegenerative disorder","volume":"2024","author":"Bhardwaj","year":"1845","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2025.115287_bb0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.exer.2015.07.014","article-title":"Loss of DJ-1 elicits retinal abnormalities, visual dysfunction, and increased oxidative stress in mice","volume":"139","author":"Bonilha","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.expneurol.2025.115287_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JPD-201981","article-title":"Mitochondria and Parkinson\u2019s disease: clinical, molecular, and translational aspects","volume":"11","author":"Borsche","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0050","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.arr.2016.02.008","article-title":"What lysosomes actually tell us about Parkinson\u2019s disease?","volume":"32","author":"Bourdenx","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2025.115287_bb0055","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1093\/hmg\/dds089","article-title":"Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis","volume":"21","author":"Bras","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2025.115287_bb0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bbamcr.2008.10.016","article-title":"Sorting of lysosomal proteins","volume":"1793","author":"Braulke","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2025.115287_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021303","article-title":"Ubiquitin carboxyl-terminal hydrolase L1 and its role in Parkinson\u2019s disease","volume":"25","author":"Buneeva","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/biom14080949","article-title":"Novel therapeutic horizons: SNCA targeting in Parkinson\u2019s disease","volume":"14","author":"Caramiello","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.expneurol.2025.115287_bb0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41531-018-0063-3","article-title":"Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice","volume":"4","author":"Cataldi","year":"2018","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0080","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1074\/mcp.M112.021980","article-title":"An extended proteome map of the lysosomal membrane reveals novel potential transporters","volume":"12","author":"Chapel","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.expneurol.2025.115287_bb0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12929-018-0454-0","article-title":"LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson\u2019s disease: a review","volume":"25","author":"Chen","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0090","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1073\/pnas.1814909116","article-title":"Parkinson\u2019s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration","volume":"116","author":"Chen","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2025.115287_bb0095","article-title":"GBA-AAV mitigates sleep disruptions and motor deficits in mice with REM sleep behavior disorder","volume":"10","author":"Chen","year":"2024","journal-title":"Npj Parkinson\u2019s Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","article-title":"A progressive mouse model of Parkinson\u2019s disease: the Thy1-aSyn (\u201cline 61\u201d) mice","volume":"9","author":"Chesselet","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2025.115287_bb0105","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1038\/s41598-020-62309-z","article-title":"The function of bacterial HtrA is evolutionally conserved in mammalian HtrA2\/Omi","volume":"10","author":"Chung","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2025.115287_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104614","article-title":"The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivo","volume":"134","author":"Cresto","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0115","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-024-05419-5","article-title":"Lysosomal dysfunction in \u03b1-synuclein pathology: molecular mechanisms and therapeutic strategies","volume":"81","author":"Dai","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"Pt 8","key":"10.1016\/j.expneurol.2025.115287_bb0120","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2025.115287_bb0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.7555\/JBR.36.20220001","article-title":"ATP13A2 protects dopaminergic neurons in Parkinson\u2019s disease: from biology to pathology","volume":"36","author":"Dang","year":"2022","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.expneurol.2025.115287_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158714","article-title":"Applications of CRISPR-Cas9 in Alzheimer\u2019s disease and related disorders","volume":"23","author":"De Plano","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/cdd.2016.104","article-title":"Deficiency of Parkinson\u2019s disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation","volume":"24","author":"Delgado-Camprubi","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2025.115287_bb0140","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/hmg\/ddx070","article-title":"ATP13A2\/PARK9 regulates endo\u2212\/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function","volume":"26","author":"Demirsoy","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2025.115287_bb0145","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s13760-014-0347-2","article-title":"Genetic analysis of SNCA coding mutation in Chinese Han patients with Parkinson disease","volume":"115","author":"Deng","year":"2015","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.expneurol.2025.115287_bb0150","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuron.2022.12.020","article-title":"Parkinson\u2019s disease genes VPS35 and EIF4G1 interact genetically and converge on alpha-Synuclein","volume":"111","author":"Dhungel","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2025.115287_bb0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbr.2018.01.029","article-title":"Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synuclein","volume":"343","author":"Dirr","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2025.115287_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136826","article-title":"Behavioral phenotyping in a murine model of GBA1-associated Parkinson disease","volume":"22","author":"Do","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0165","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0170","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40035-023-00368-8","article-title":"Animal models of Parkinson\u2019s disease: bridging the gap between disease hallmarks and research questions","volume":"12","author":"Dovonou","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.expneurol.2025.115287_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.01272","article-title":"VPS35-based approach: a potential innovative treatment in Parkinson\u2019s disease","volume":"10","author":"Eleuteri","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.expneurol.2025.115287_bb0180","article-title":"Adult-onset deletion of ATP13A2 in mice induces progressive nigrostriatal pathway dopaminergic degeneration and lysosomal abnormalities","volume":"10","author":"Erb","year":"2024","journal-title":"Npj Parkinson\u2019s Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0185","article-title":"Four copies of SNCA responsible for autosomal dominant Parkinson\u2019s disease in two Italian siblings","volume":"2015","author":"Ferese","year":"2015","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0190","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ane.12616","article-title":"An updated review of Parkinson\u2019s disease genetics and clinicopathological correlations","volume":"135","author":"Ferreira","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.expneurol.2025.115287_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/biom14070870","article-title":"Leucine-rich repeat Kinase-2 controls the differentiation and maturation of oligodendrocytes in mice and zebrafish","volume":"14","author":"Filippini","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.expneurol.2025.115287_bb0200","article-title":"Functional characterization of extrinsic tongue muscles in the Pink1\u2212\/\u2212 rat model of Parkinson disease","volume":"15","author":"Fleming","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2025.115287_bb0205","first-page":"8","article-title":"Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous \u03b1-synuclein in human neurons","author":"Fonseca-Ornelas","year":"2022","journal-title":"Npj Parkinson\u2019s Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0210","article-title":"The homozygous LRRK2.P.N1437D point mutation mouse is a novel model of parkinsonism","volume":"11","author":"Gan","year":"2025","journal-title":"Npj Parkinson\u2019s Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129487","article-title":"Brain-penetrant cyanoindane and cyanotetralin inhibitors of G2019S-LRRK2 kinase activity","volume":"95","author":"Garofalo","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.expneurol.2025.115287_bb0220","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-00367-7","article-title":"PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease","volume":"15","author":"Ge","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2025.115287_bb0225","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.expneurol.2012.01.002","article-title":"Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb","volume":"235","author":"Glasl","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2025.115287_bb0230","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1152\/physrev.00027.2001","article-title":"The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction","volume":"82","author":"Glickman","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.expneurol.2025.115287_bb0235","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/CON.0000000000000309","article-title":"Lewy body dementias: dementia with Lewy bodies and Parkinson disease dementia","volume":"22","author":"Gomperts","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.expneurol.2025.115287_bb0240","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/jnr.23625","article-title":"Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson\u2019s disease","volume":"93","author":"Grant","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2025.115287_bb0245","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179633","article-title":"Deficiency of parkin causes neurodegeneration and accumulation of pathological alpha-synuclein in monkey models","volume":"134","author":"Han","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2025.115287_bb0250","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.parkreldis.2008.07.010","article-title":"Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes","volume":"15","author":"Hasegawa","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2025.115287_bb0255","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020104494","article-title":"LRRK2 activation controls the repair of damaged endomembranes in macrophages","volume":"39","author":"Herbst","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2025.115287_bb0260","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/15548627.2019.1603545","article-title":"Age-dependent accumulation of oligomeric SNCA\/\u03b1-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA)","volume":"16","author":"Ho","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2025.115287_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116261","article-title":"A53T \u03b1-synuclein mutation increases susceptibility to postoperative delayed neurocognitive recovery via hippocampal Ang-(1\u20137)\/MasR axis","volume":"224","author":"Hong","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2025.115287_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115475","article-title":"Small-molecule LRRK2 inhibitors for PD therapy: current achievements and future perspectives","volume":"256","author":"Hu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.expneurol.2025.115287_bb0275","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/jcsm.13604","article-title":"LRRK2G2019S gene mutation causes skeletal muscle impairment in animal model of Parkinson\u2019s disease","volume":"15","author":"Hu","year":"2024","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.expneurol.2025.115287_bb0280","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.045815","article-title":"Machine learning discriminates a movement disorder in a zebrafish model of Parkinson\u2019s disease","volume":"13","author":"Hughes","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.expneurol.2025.115287_bb0285","first-page":"4507","article-title":"Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice","volume":"25","author":"Ishizu","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2025.115287_bb0290","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","article-title":"Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders","volume":"39","author":"Islam","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.expneurol.2025.115287_bb0295","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1080\/15548627.2018.1491489","article-title":"The lysosomal membrane protein LAMP2A promotes autophagic flux and prevents SNCA-induced Parkinson disease-like symptoms in the Drosophila brain","volume":"14","author":"Issa","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2025.115287_bb0300","doi-asserted-by":"crossref","first-page":"E4016","DOI":"10.1073\/pnas.1309143110","article-title":"Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model","volume":"110","author":"Janezic","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2025.115287_bb0305","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1093\/cercor\/bhu318","article-title":"Corticospinal motor neurons are susceptible to increased ER stress and display profound degeneration in the absence of UCHL1 function","volume":"25","author":"Jara","year":"2015","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.expneurol.2025.115287_bb0310","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj2658","article-title":"Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson\u2019s disease","volume":"14","author":"Jennings","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2025.115287_bb0315","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuroscience.2020.06.001","article-title":"Down-regulation of DJ-1 augments Neuroinflammation via Nrf2\/Trx1\/NLRP3 Axis in MPTP-induced Parkinson\u2019s disease mouse model","volume":"442","author":"Ji","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2025.115287_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105313","article-title":"Impaired neurogenesis in the hippocampus of an adult VPS35 mutant mouse model of Parkinson\u2019s disease through interaction with APP","volume":"153","author":"Jiang","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105513","article-title":"Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological alpha-synuclein spread in the prodromal preformed fibrils model in young mice","volume":"159","author":"Johnson","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0330","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nbd.2017.04.014","article-title":"Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson\u2019s disease phenotypes","volume":"104","author":"Julienne","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0335","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/ane.12563","article-title":"The genetic background of Parkinson\u2019s disease: current progress and future prospects","volume":"134","author":"Kalinderi","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.expneurol.2025.115287_bb0340","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201600092","article-title":"Leucine-rich repeat kinase 2 and Parkinson\u2019s disease","volume":"17","author":"Kang","year":"2017","journal-title":"Proteomics"},{"key":"10.1016\/j.expneurol.2025.115287_bb0345","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/febs.13127","article-title":"PINK1 and Parkin \u2013 mitochondrial interplay between phosphorylation and ubiquitylation in Parkinson\u2019s disease","volume":"282","author":"Kazlauskaite","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.expneurol.2025.115287_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.660843","article-title":"Mitochondrial CHCHD2: disease-associated mutations, physiological functions, and current animal models","volume":"13","author":"Kee","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2017.12.002","article-title":"Characterization of early-onset motor deficits in the Pink1\u2212\/\u2212 mouse model of Parkinson disease","volume":"1680","author":"Kelm-Nelson","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2025.115287_bb0360","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1523\/JNEUROSCI.0632-14.2015","article-title":"Alpha-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal parkinsonism protein Atp13a2","volume":"35","author":"Kett","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24109088","article-title":"Parkinson\u2019s disease: exploring different animal model systems","volume":"24","author":"Khan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0370","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/ars.2006.8.152","article-title":"Oxidative stress and autophagy","volume":"8","author":"Kiffin","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.expneurol.2025.115287_bb0375","first-page":"8","article-title":"Dysregulated mRNA translation in the G2019S LRRK2 and LRRK2 Knock-out mouse brains","author":"Kim","year":"2021","journal-title":"Eneuro"},{"key":"10.1016\/j.expneurol.2025.115287_bb0380","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4161\/auto.27367","article-title":"The vacuole versus the lysosome: when size matters","volume":"10","author":"Klionsky","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2025.115287_bb0385","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.expneurol.2025.115287_bb0390","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.omtn.2020.06.027","article-title":"Splice-switching antisense oligonucleotides reduce LRRK2 kinase activity in human LRRK2 transgenic mice","volume":"21","author":"Korecka","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.expneurol.2025.115287_bb0395","article-title":"The A53T mutation in \u03b1-Synuclein enhances Proinflammatory activation in human microglia upon inflammatory stimulus","author":"Krzisch","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2025.115287_bb0400","article-title":"S-nitrosylation of UCHL1 induces its structural instability and promotes \u03b1-synuclein aggregation","volume":"7","author":"Kumar","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2025.115287_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114080","article-title":"Discovery of G2019S-selective leucine rich repeat protein kinase 2 inhibitors with in vivo efficacy","volume":"229","author":"Lesniak","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.expneurol.2025.115287_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102319","article-title":"Modulating \u03b1-synuclein propagation and decomposition: implications in Parkinson\u2019s disease therapy","volume":"98","author":"Li","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2025.115287_bb0415","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12017-023-08755-0","article-title":"The role of ubiquitin\u2013proteasome system and mitophagy in the pathogenesis of Parkinson\u2019s disease","volume":"25","author":"Liang","year":"2023","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.expneurol.2025.115287_bb0420","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuron.2009.11.006","article-title":"Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson\u2019s-disease-related mutant \u03b1-synuclein","volume":"64","author":"Lin","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2025.115287_bb0425","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73753","article-title":"Glial Nrf2 signaling mediates the neuroprotection exerted by Gastrodia elata Blume in Lrrk2-G2019S Parkinson\u2019s disease","volume":"10","author":"Lin","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.expneurol.2025.115287_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112890","article-title":"Mitochondria-associated membranes: a hub for neurodegenerative diseases","volume":"149","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.expneurol.2025.115287_bb0435","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1073\/pnas.0708452105","article-title":"A Drosophila model for LRRK2-linked parkinsonism","volume":"105","author":"Liu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2025.115287_bb0440","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/acn3.45","article-title":"LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity","volume":"1","author":"Liu","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.expneurol.2025.115287_bb0445","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10072-014-1987-y","article-title":"Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson\u2019s disease: the impact of ethnicity and onset age","volume":"36","author":"Liu","year":"2014","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0450","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1080\/15548627.2020.1850008","article-title":"Aberrant mitochondrial morphology and function associated with impaired mitophagy and DNM1L-MAPK\/ERK signaling are found in aged mutant parkinsonian LRRK2(R1441G) mice","volume":"17","author":"Liu","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.expneurol.2025.115287_bb0455","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"\u0391-Synuclein misfolding and aggregation: implications in Parkinson\u2019s disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochim. Biophys. Acta Proteins Proteomics"},{"key":"10.1016\/j.expneurol.2025.115287_bb0460","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15500","article-title":"Loss of Parkinson\u2019s disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c","volume":"8","author":"Meng","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2025.115287_bb0465","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/brain\/awac087","article-title":"Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism","volume":"145","author":"Merino-Galan","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2025.115287_bb0470","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00210-019-01737-9","article-title":"Neurorestorative effects of sub-chronic administration of ambroxol in rodent model of Parkinson\u2019s disease","volume":"393","author":"Mishra","year":"2020","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.expneurol.2025.115287_bb0475","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2016.12.001","article-title":"Role of the VPS35 D620N mutation in Parkinson\u2019s disease","volume":"36","author":"Mohan","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2025.115287_bb0480","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mds.26562","article-title":"Lysosomal dysfunction and alpha-Synuclein aggregation in Parkinson\u2019s disease: diagnostic links","volume":"31","author":"Moors","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2025.115287_bb0485","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/13543776.2024.2378076","article-title":"Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson\u2019s disease: a patent review of the literature to date","volume":"34","author":"Morez","year":"2024","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.expneurol.2025.115287_bb0490","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2025.115287_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00120","article-title":"PINK1\/Parkin-dependent mitochondrial surveillance: from pleiotropy to Parkinson\u2019s disease","volume":"10","author":"Mouton-Liger","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102283","article-title":"Modulation of signaling pathways by DJ-1: an updated overview","volume":"51","author":"Neves","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.expneurol.2025.115287_bb0505","doi-asserted-by":"crossref","first-page":"11257","DOI":"10.1523\/JNEUROSCI.2375-09.2009","article-title":"Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila","volume":"29","author":"Ng","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0510","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13347","article-title":"VPS35 D620N knockin mice recapitulate cardinal features of Parkinson\u2019s disease","volume":"20","author":"Niu","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.expneurol.2025.115287_bb0515","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41580-024-00757-5","article-title":"Mechanisms of autophagy\u2013lysosome dysfunction in neurodegenerative diseases","volume":"25","author":"Nixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.expneurol.2025.115287_bb0520","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.821839","article-title":"The gentle side of the UPS: ubiquitin-proteasome system and the regulation of the myogenic program","volume":"9","author":"Olgu\u00edn","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.expneurol.2025.115287_bb0525","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","article-title":"Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u2019s disease","volume":"30","author":"Pagano","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2025.115287_bb0530","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.biochem.70.1.503","article-title":"Mechanisms underlying ubiquitination","volume":"70","author":"Pickart","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.expneurol.2025.115287_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134417","article-title":"Effective lowering of \u03b1-synuclein expression by targeting G-quadruplex structures within the SNCA gene","volume":"277","author":"Pirota","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.expneurol.2025.115287_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105612","article-title":"A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degeneration","volume":"163","author":"Polissidis","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0545","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","article-title":"Mapping of a gene for Parkinson\u2019s disease to chromosome 4q21-q23","volume":"274","author":"Polymeropoulos","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2025.115287_bb0550","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2025.115287_bb0555","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00163","article-title":"Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents \u03b1-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy","volume":"9","author":"Puka\u00df","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0560","doi-asserted-by":"crossref","DOI":"10.1007\/s10158-020-00244-4","article-title":"Knockout of PINK1 altered the neural connectivity of Drosophila dopamine PPM3 neurons at input and output sites","volume":"20","author":"Qiao","year":"2020","journal-title":"Invertebr. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0565","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2025.115287_bb0570","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.molcel.2023.11.016","article-title":"Ubiquiton\u2014an inducible, linkage-specific polyubiquitylation tool","volume":"84","author":"Renz","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.expneurol.2025.115287_bb0575","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1074\/jbc.RA118.005008","article-title":"The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A","volume":"294","author":"Rivero-Rios","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2025.115287_bb0580","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tins.2021.12.002","article-title":"LRRK2 and idiopathic Parkinson\u2019s disease","volume":"45","author":"Rocha","year":"2022","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0585","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00109-021-02174-z","article-title":"Gaucher disease - more than just a rare lipid storage disease","volume":"100","author":"Roh","year":"2022","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.expneurol.2025.115287_bb0590","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/humu.22075","article-title":"Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe","volume":"33","author":"Rubio","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.expneurol.2025.115287_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113774","article-title":"Longitudinal assessment of skilled forelimb motor impairments in DJ-1 knockout rats","volume":"424","author":"Sanchez","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2025.115287_bb0600","doi-asserted-by":"crossref","first-page":"31380","DOI":"10.1038\/srep31380","article-title":"Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models","volume":"6","author":"Sanchez-Martinez","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2025.115287_bb0605","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1073\/pnas.1220464110","article-title":"Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies","volume":"110","author":"Sardi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2025.115287_bb0610","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10571-020-00849-8","article-title":"The role of VPS35 in the pathobiology of Parkinson\u2019s disease","volume":"41","author":"Sassone","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2025.115287_bb0615","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/hmg\/ddab057","article-title":"Homeostatic p62 levels and inclusion body formation in CHCHD2 knockout mice","volume":"30","author":"Sato","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2025.115287_bb0620","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tcb.2007.07.009","article-title":"ROS, mitochondria and the regulation of autophagy","volume":"17","author":"Scherz-Shouval","year":"2007","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.expneurol.2025.115287_bb0625","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/hmg\/ddt057","article-title":"Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited alpha-synuclein accumulation and age-dependent sensorimotor deficits","volume":"22","author":"Schultheis","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2025.115287_bb0630","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3389\/fnins.2020.00674","article-title":"Progress in LRRK2-associated Parkinson\u2019s disease animal models","volume":"14","author":"Seegobin","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0635","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1111\/febs.13249","article-title":"Parkin structure and function","volume":"282","author":"Seirafi","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.expneurol.2025.115287_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105267","article-title":"Multiple genetic pathways regulating lifespan extension are neuroprotective in a G2019S LRRK2 nematode model of Parkinson\u2019s disease","volume":"151","author":"Senchuk","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0645","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.945","article-title":"Transgenic LRRK2 (R1441G) rats-a model for Parkinson disease?","volume":"3","author":"Shaikh","year":"2015","journal-title":"PeerJ"},{"key":"10.1016\/j.expneurol.2025.115287_bb0650","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312740","article-title":"Glitazone treatment rescues phenotypic deficits in a Fly model of Gaucher\/Parkinson\u2019s disease","volume":"22","author":"Shola-Dare","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0655","article-title":"Nigral ATP13A2 depletion induces Parkinson\u2019s disease-related neurodegeneration in a pilot study in non-human primates","volume":"10","author":"Sikora","year":"2024","journal-title":"Npj Parkinson\u2019s Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.expneurol.2025.115287_bb0665","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.tins.2005.05.009","article-title":"Altered alpha-synuclein homeostasis causing Parkinson\u2019s disease: the potential roles of dardarin","volume":"28","author":"Singleton","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0670","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/hmg\/ddv628","article-title":"LRRK2 BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function","volume":"25","author":"Sloan","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2025.115287_bb0675","doi-asserted-by":"crossref","DOI":"10.3390\/cells11081261","article-title":"GBA variants and Parkinson disease: mechanisms and treatments","volume":"11","author":"Smith","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.expneurol.2025.115287_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129754","article-title":"The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-\u03baB signaling pathway","volume":"1865","author":"Spagnol","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.expneurol.2025.115287_bb0685","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/path.5312","article-title":"Loss of FBXO7 results in a Parkinson\u2019s-like dopaminergic degeneration via an RPL23\u2013MDM2\u2013TP53 pathway","volume":"249","author":"Stott","year":"2019","journal-title":"J. Pathol."},{"key":"10.1016\/j.expneurol.2025.115287_bb0690","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1515\/revneuro-2018-0004","article-title":"Progress in research on the role of Omi\/HtrA2 in neurological diseases","volume":"30","author":"Su","year":"2019","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0695","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020407","article-title":"Invertebrate models untangle the mechanism of neurodegeneration in Parkinson\u2019s disease","volume":"10","author":"Surguchov","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.expneurol.2025.115287_bb0700","doi-asserted-by":"crossref","first-page":"24310","DOI":"10.1073\/pnas.1903268116","article-title":"Hsp110 mitigates alpha-synuclein pathology in vivo","volume":"116","author":"Taguchi","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2025.115287_bb0705","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21061961","article-title":"Animal model for prodromal Parkinson\u2019s disease","volume":"21","author":"Taguchi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0710","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1523\/JNEUROSCI.0042-15.2015","article-title":"VPS35 in dopamine neurons is required for endosome-to-Golgi retrieval of Lamp2a, a receptor of chaperone-mediated autophagy that is critical for alpha-Synuclein degradation and prevention of pathogenesis of Parkinson\u2019s disease","volume":"35","author":"Tang","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115287_bb0715","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ymgme.2017.11.001","article-title":"Glucocerebrosidase haploinsufficiency in A53T alpha-synuclein mice impacts disease onset and course","volume":"122","author":"Tayebi","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.expneurol.2025.115287_bb0720","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-7-2","article-title":"Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway","volume":"7","author":"Tong","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2025.115287_bb0725","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-22804-w","article-title":"Drosophila ubiquitin C-terminal hydrolase knockdown model of Parkinson\u2019s disease","volume":"8","author":"Tran","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2025.115287_bb0730","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00221-023-06765-9","article-title":"Autophagy and UPS pathway contribute to nicotine-induced protection effect in Parkinson\u2019s disease","volume":"242","author":"Ullah","year":"2024","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.expneurol.2025.115287_bb0735","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41586-020-1968-7","article-title":"ATP13A2 deficiency disrupts lysosomal polyamine export","volume":"578","author":"van Veen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2025.115287_bb0740","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13041-020-00704-3","article-title":"Altered striatal dopamine levels in Parkinson\u2019s disease VPS35 D620N mutant transgenic aged mice","volume":"13","author":"Vanan","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.expneurol.2025.115287_bb0745","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12035-014-8927-y","article-title":"Early expression of Parkinson\u2019s disease-related mitochondrial abnormalities in PINK1 knockout rats","volume":"53","author":"Villeneuve","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2025.115287_bb0750","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.15252\/embj.201593585","article-title":"Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice","volume":"35","author":"Vingill","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.expneurol.2025.115287_bb0755","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113022","article-title":"Disruption of mitochondrial homeostasis: the role of PINK1 in Parkinson\u2019s disease","volume":"10","author":"Vizziello","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.expneurol.2025.115287_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108843","article-title":"Progress of immunotherapy of anti-alpha-synuclein in Parkinson\u2019s disease","volume":"115","author":"Wang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.expneurol.2025.115287_bb0765","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.freeradbiomed.2024.11.034","article-title":"Neuroprotective role of CHCHD2 in Parkinson\u2019s disease: insights into the GPX4-related ferroptosis pathway","volume":"226","author":"Wang","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.expneurol.2025.115287_bb0770","first-page":"14","article-title":"Dysregulated Wnt and NFAT signaling in a Parkinson\u2019s disease LRRK2 G2019S knock-in model","author":"Wetzel","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2025.115287_bb0775","doi-asserted-by":"crossref","DOI":"10.1186\/1747-1028-2-11","article-title":"The ubiquitination code: a signalling problem","volume":"2","author":"Woelk","year":"2007","journal-title":"Cell Div"},{"key":"10.1016\/j.expneurol.2025.115287_bb0780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"Alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2025.115287_bb0785","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb1540","article-title":"Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson\u2019s disease-linked DNAJC6 mutations","volume":"7","author":"Wulansari","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.expneurol.2025.115287_bb0790","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/hmg\/ddr521","article-title":"Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system","volume":"21","author":"Xilouri","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2025.115287_bb0795","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.parkreldis.2018.12.014","article-title":"Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson\u2019s disease: risk estimates and genotype-phenotype correlations","volume":"62","author":"Yahalom","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2025.115287_bb0800","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/371256","article-title":"Mutations in the ATP13A2 gene and parkinsonism: a preliminary review","volume":"2014","author":"Yang","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.expneurol.2025.115287_bb0805","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbr.2017.10.036","article-title":"Characterization of oromotor and limb motor dysfunction in the DJ1 \u2212\/\u2212 model of Parkinson disease","volume":"339","author":"Yang","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2025.115287_bb0810","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13238-021-00888-x","article-title":"PINK1 kinase dysfunction triggers neurodegeneration in the primate brain without impacting mitochondrial homeostasis","volume":"13","author":"Yang","year":"2022","journal-title":"Protein Cell"},{"key":"10.1016\/j.expneurol.2025.115287_bb0815","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nbd.2010.04.002","article-title":"LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson\u2019s disease","volume":"40","author":"Yao","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0820","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1471-4159.2008.05827.x","article-title":"Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson\u2019s disease","volume":"108","author":"Yasuda","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2025.115287_bb0825","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-03913-3","article-title":"Mitochondrial Ca2+ oscillation induces mitophagy initiation through the PINK1-Parkin pathway","volume":"12","author":"Yu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0233-5","article-title":"Alpha-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism","volume":"13","author":"Yun","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2025.115287_bb0835","article-title":"Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant alpha-synuclein","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2025.115287_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113768","article-title":"Progress in Parkinson\u2019s disease animal models of genetic defects: characteristics and application","volume":"155","author":"Zhang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.expneurol.2025.115287_bb0845","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000367995","article-title":"<b><i>UCH-L1<\/i><\/b> S18Y variant and risk of Parkinson\u2019s disease in Asian populations: an updated meta-analysis","volume":"14","author":"Zhu","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.expneurol.2025.115287_bb0850","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1126\/science.adi9926","article-title":"Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2","volume":"382","author":"Zhu","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2025.115287_bb0855","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625001517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625001517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:00:54Z","timestamp":1762149654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488625001517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":171,"alternative-id":["S0014488625001517"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115287","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene-modified animal models of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115287"}}